glp 1 for ckd Kidney and Cardiovascular Outcomes Among Patients With Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Recommendations for SGLT2i versus GLP-1

[1] [2] However, as with all medications, ongoing surveillance remains essential, particularly as real-world use expands beyond the populations studied in clinical trials

Marathe CS, Rayner CK, Jones KL, Horowitz M (2013) Glucagon-like peptides 1 and 2 in health and disease: a review

Similarly, cerebrospinal fluid (CSF) biomarkers provide insight into neuronal injury but, rather than contextualizing the underlying genomic contributions, they may only aid gene discovery (Neumann et al., 2023

Around the 4 month period , I begin to notice that I am clenching my jaw more often, which is my sign to get another treatment

doi: 10.1186/s12937-024-00934-4 22